Clinical Trial Update: IMMunological resPonse Assessment afteR Acute iSchemic Stroke Treated With Endovascular Therapy (IMPRESS)

View source ↗

Summary

IMPRESS is a clinical trial assessing immunological response after acute ischemic stroke treated with endovascular therapy; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild | Conditions: Ischemic Stroke, Thrombectomy | Status: RECRUITING